Time-dependent lipid response on fluvastatin therapy of patients with hypercholesterolemia sensitive to apoE phenotype-Reference-Cited by-同舟云学术

Time-dependent lipid response on fluvastatin therapy of patients with hypercholesterolemia sensitive to apoE phenotype

Published:2003-12 Issue:5 Volume:40 Page:237-245
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

Dergunov Alexander D,Perova Natalya V,Visvikis Sophie,Siest Gerard

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine,Physiology

Reference37 articles.

1. The hypolipidemic effect of and tolerance for Lescol in treating hypercholesterolemia in hypertension patients (an analysis of the data from a multicenter study);Aronov;Ther. Arch. (Russia),1995

2. Quantification of high-density lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2;Assmann;Clin. Chem.,1983

3. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk;Austin;Circulation,1990

4. Lipoprotein metabolism;Beisiegel;Eur. Heart J.,1998

5. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein;Beisiegel;Nature,1989

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Camellia sinensis polysaccharide attenuates inflammatory responses via the ROS-mediated pathway by endocytosis;International Journal of Biological Macromolecules;2024-05

2. Associations between SLCO1B1, APOE and CYP2C9 and lipid-lowering efficacy and pharmacokinetics of fluvastatin: a meta-analysis;Pharmacogenomics;2023-06

3. Fluvastatin for lowering lipids;Cochrane Database of Systematic Reviews;2018-03-06

4. Apolipoprotein E genotype as a most significant predictor of lipid response at lipid-lowering therapy: Mechanistic and clinical studies;Biomedicine & Pharmacotherapy;2011-12

5. Effect of apolipoprotein E polymorphism on statin-induced decreases in plasma lipids and cardiovascular events;Drug Metabolism and Drug Interactions;2011-01-01